Home The Word Brain My Amedeo FAQ Privacy About   


CC Journal Club

Our weekly journal club for junior residents and medical students


  Nuclear Medicine

  Free Subscription


Articles published in Ann Neurol

Retrieve available abstracts of 22 articles:
HTML format



Single Articles


    April 2025
  1. BROWN EG, Chahine LM, Siderowf A, Gochanour C, et al
    Staged Screening Identifies People with Biomarkers Related to Neuronal Alpha-Synuclein Disease.
    Ann Neurol. 2025;97:730-740.
    PubMed     Abstract available


    March 2025
  2. LAGARDE J, Maiti P, Schonhaut DR, Blazhenets G, et al
    Amyloid PET in Sporadic Early- Versus Late-Onset Alzheimer's Disease: Comparison of the LEADS and ADNI Cohorts.
    Ann Neurol. 2025 Mar 17. doi: 10.1002/ana.27233.
    PubMed     Abstract available


    February 2025
  3. CANOSA A, Manera U, Vasta R, Zocco G, et al
    Brain Metabolic Features of FUS-ALS: A 2-[(18)F]FDG-PET Study.
    Ann Neurol. 2025 Feb 20. doi: 10.1002/ana.27201.
    PubMed     Abstract available


    January 2025
  4. LI J, Chen D, Tang Y, Chen Z, et al
    Synaptic Density Reductions in MSA: A Potential Biomarker Identified Through [(18)F]SynVesT-1 PET Imaging.
    Ann Neurol. 2025 Jan 19. doi: 10.1002/ana.27179.
    PubMed     Abstract available


    December 2024
  5. BRIER MR, Judge B, Ying C, Salter A, et al
    Increased White Matter Aerobic Glycolysis in Multiple Sclerosis.
    Ann Neurol. 2024 Dec 23. doi: 10.1002/ana.27165.
    PubMed     Abstract available


    October 2024
  6. ENGELS-DOMINGUEZ N, Riphagen JM, Van Egroo M, Koops EA, et al
    Lower Locus Coeruleus Integrity Signals Elevated Entorhinal Tau and Clinical Progression in Asymptomatic Older Individuals.
    Ann Neurol. 2024;96:650-661.
    PubMed     Abstract available


    September 2024
  7. MUTIMER CA, Mujanovic A, Kaesmacher J, Churilov L, et al
    Comparison of Perfusion Imaging Definitions of the No-Reflow Phenomenon after Thrombectomy-What Is the Best Perfusion Imaging Definition?
    Ann Neurol. 2024 Sep 3. doi: 10.1002/ana.27073.
    PubMed     Abstract available


  8. BRUMBERG J, Blazhenets G, Buhler S, Fostitsch J, et al
    Cerebral Glucose Metabolism Is a Valuable Predictor of Survival in Patients with Lewy Body Diseases.
    Ann Neurol. 2024;96:539-550.
    PubMed     Abstract available


    August 2024
  9. BITZER F, Walger L, Bauer T, Schulte F, et al
    Higher Validity, Lower Radiation: A New Ictal Single-Photon Emission Computed Tomography Framework.
    Ann Neurol. 2024 Aug 21. doi: 10.1002/ana.27061.
    PubMed     Abstract available


  10. HIRATA K, Matsuoka K, Tagai K, Endo H, et al
    In Vivo Assessment of Astrocyte Reactivity in Patients with Progressive Supranuclear Palsy.
    Ann Neurol. 2024;96:247-261.
    PubMed     Abstract available


    June 2024
  11. SOLEIMANI-MEIGOONI DN, Smith R, Provost K, Lesman-Segev OH, et al
    Head-to-Head Comparison of Tau and Amyloid Positron Emission Tomography Visual Reads for Differential Diagnosis of Neurodegenerative Disorders: An International, Multicenter Study.
    Ann Neurol. 2024 Jun 18. doi: 10.1002/ana.27008.
    PubMed     Abstract available


    May 2024
  12. SAARINEN EK, Kuusimaki T, Lindholm K, Niemi K, et al
    Dietary Caffeine and Brain Dopaminergic Function in Parkinson Disease.
    Ann Neurol. 2024 May 20. doi: 10.1002/ana.26957.
    PubMed     Abstract available


  13. LAN G, Chen X, Yang J, Sun P, et al
    Microglial Reactivity Correlates with Presynaptic Loss Independent of beta-Amyloid and Tau.
    Ann Neurol. 2024;95:917-928.
    PubMed     Abstract available


    April 2024
  14. GARCIA-CORDERO I, Anastassiadis C, Khoja A, Morales-Rivero A, et al
    Evaluating the Effect of Alzheimer's Disease-Related Biomarker Change in Corticobasal Syndrome and Progressive Supranuclear Palsy.
    Ann Neurol. 2024 Apr 5. doi: 10.1002/ana.26930.
    PubMed     Abstract available


    March 2024
  15. ARNALDI D, Mattioli P, Raffa S, Pardini M, et al
    Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy.
    Ann Neurol. 2024 Mar 11. doi: 10.1002/ana.26902.
    PubMed     Abstract available


  16. PAPP KV, Jutten RJ, Soberanes D, Weizenbaum E, et al
    Early Detection of Amyloid-Related Changes in Memory among Cognitively Unimpaired Older Adults with Daily Digital Testing.
    Ann Neurol. 2024;95:507-517.
    PubMed     Abstract available


    February 2024
  17. LI Y, Yen D, Hendrix RD, Gordon BA, et al
    Timing of Biomarker Changes in Sporadic Alzheimer's Disease in Estimated Years from Symptom Onset.
    Ann Neurol. 2024 Feb 24. doi: 10.1002/ana.26891.
    PubMed     Abstract available


  18. CHEN X, Toueg TN, Harrison TM, Baker SL, et al
    Regional Tau Deposition Reflects Different Pathways of Subsequent Neurodegeneration and Memory Decline in Cognitively Normal Older Adults.
    Ann Neurol. 2024;95:249-259.
    PubMed     Abstract available


    December 2023
  19. BONOMI S, Lu R, Schindler SE, Bui Q, et al
    Relationships of Cognitive Measures with Cerebrospinal Fluid but not Imaging Biomarkers of Alzheimer Disease Vary between Black and White Individuals.
    Ann Neurol. 2023 Dec 1. doi: 10.1002/ana.26838.
    PubMed     Abstract available


    November 2023
  20. CHUN MY, Chung SJ, Kim SH, Park CW, et al
    Hippocampal Perfusion Affects Motor and Cognitive Functions in Parkinson's Disease: An Early-Phase (18) F-FP-CIT PET Study.
    Ann Neurol. 2023 Nov 14. doi: 10.1002/ana.26827.
    PubMed     Abstract available


    October 2023
  21. ZHENG L, Rubinski A, Dennecke J, Luan Y, et al
    Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer's Disease.
    Ann Neurol. 2023 Oct 14. doi: 10.1002/ana.26818.
    PubMed     Abstract available


    July 2023
  22. PISANI L, Haussen DC, Mohammaden M, Perry da Camara C, et al
    Comparison of CT Perfusion Software Packages for Thrombectomy Eligibility.
    Ann Neurol. 2023 Jul 25. doi: 10.1002/ana.26748.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.